EVOLVE platform, a trispecific T cell engager with integrated CD2 costimulation, for the treatment of solid and hematologic tumors. - Sergeeva OA; Jin G; Sarkar M; Zeiger J; Dhindwal S; Chin SS; Abulizi A; Lai Z; Brown C; DeMaria WG; Ryan D; An X; et al. (Proceedings of the National Academy of Sciences of the United States of America, 2025)